Scientists hunt for clues to dangerous drug allergies in young leukemia patients
NCT ID NCT07499336
First seen Mar 30, 2026 · Last updated May 12, 2026 · Updated 8 times
Summary
This study aims to find biological markers that can predict which children and young adults with acute lymphoblastic leukemia (ALL) will have severe allergic reactions to the chemotherapy drug PEG-asparaginase. Researchers will collect blood and bone marrow samples from 45 patients (20 with allergies and 20 without) and analyze immune cells to understand why some develop these reactions. The goal is to develop a simple blood test that can identify at-risk patients without needing invasive bone marrow sampling.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKAEMIA - CATEGORY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.